free encyclopedia systemic lupus erythematosus jump navigation jump search article type systemic lupus erythematosus
group disease known systemic lupus erythematosus see systemic lupus erythematosus erythematosus
systemic lupus erythematosus systemic lupus erythematosus redirect
use see systemic lupus erythematosus disambiguation systemic lupus erythematosus disambiguation
systemic lupus erythematosus name systemic lupus erythematosus systemic lupus erythematosus young woman typical butterfly rash found systemic lupus erythematosus pronunciation
rheumatology symptom painful swollen joint fever chest pain hair loss mouth ulcer swollen lymph node feel tire red rash usual onset year age duration long term cause diagnostic method base symptom blood test nsaids corticosteroid methotrexate year survival frequency
systemic lupus erythematosus systemic lupus erythematosus known simply systemic lupus erythematosus autoimmune disease body immune system mistakenly attack healthy tissue part body symptom vary people mild severe common symptom include painful swollen joint fever chest pain hair loss mouth ulcer swollen lymph node feel tire red rash commonly face period illness call flare period remission symptom
cause systemic lupus erythematosus clear thought involve genetics together environmental factor identical twin affect chance well female sex hormone sunlight smoke vitamin d deficiency certain infection believe increase risk mechanism involve immune response autoantibody person tissue commonly anti-nuclear antibody result inflammation diagnosis difficult base combination symptom laboratory test number kind systemic lupus erythematosus erythematosus systemic lupus erythematosus neonatal systemic lupus erythematosus cutaneous systemic lupus erythematosus
cure systemic lupus erythematosus treatment include nsaids corticosteroid hydroxychloroquine alternative medicine show affect disease life expectancy lower people systemic lupus erythematosus systemic lupus erythematosus significantly increase risk cardiovascular disease common cause death modern treatment affect survive year women systemic lupus erythematosus pregnancy higher risk mostly successful
rate systemic lupus erythematosus vary country women childbear age affect time men commonly begin age wide range age affect african caribbean chinese descent higher risk white people rate disease develop world unclear systemic lupus erythematosus latin wolf disease so-nam century rash thought appear wolf bite content
sign symptom skin muscle bone blood heart eye reproductive systemic causes genetics drug reaction form systemic lupus erythematosus cell death clearance deficiency germinal center diagnosis laboratory test diagnostic criteria treatment lifestyle change kidney transplantation syndrome management pregnancy epidemiology sex chang rate disease history classical period period modern period research see reference external link
sign symptom common symptom systemic lupus erythematosus
systemic lupus erythematosus disease known great imitator mimics mistaken illness systemic lupus erythematosus classical item differential diagnosis systemic lupus erythematosus symptom vary widely come go unpredictably
diagnosis elusive people unexplain symptom systemic lupus erythematosus year
common initial chronic complaint include fever malaise joint pain muscle pain fatigue
symptom seen association disease sign symptom part diagnostic criteria systemic lupus erythematosus
occure conjunction sign symptom consider suggestive
systemic lupus erythematosus occur male female found far women symptom associate sex different female tend greater number relapse low white blood cell count arthritis phenomenon psychiatric symptom
male tend seizure kidney disease inflammation tissue line lung heart skin problem peripheral neuropathy skin
people systemic lupus erythematosus skin symptom
main category lesion chronic cutaneous discoid systemic lupus erythematosus cutaneous systemic lupus erythematosus acute cutaneous systemic lupus erythematosus
people systemic lupus erythematosus exhibit thick red scaly patche skin
similarly cutaneous systemic lupus erythematosus manifest red scaly patche skin distinct edge
acute cutaneous systemic lupus erythematosus manifest rash
classic malar rash butterfly rash associate disease rash occur people systemic lupus erythematosus
hair loss mouth nasal ulcer lesion skin possible manifestation muscle bone
commonly sought medical attention joint pain small joint hand wrist usually affect joint risk
percent affect experience joint muscle pain time course illness rheumatoid arthritis systemic lupus erythematosus arthritis disable usually cause severe destruction joint
percent people systemic lupus erythematosus arthritis develop deformity hand feet people systemic lupus erythematosus particular risk develop tuberculosis
possible association rheumatoid arthritis systemic lupus erythematosus suggest systemic lupus erythematosus associate increase risk bone fracture relatively young women blood
common children systemic lupus erythematosus develop case low platelet white blood cell count due disease side effect pharmacological treatment
people systemic lupus erythematosus association antibody syndrome thrombotic disorder wherein autoantibody phospholipid present serum
abnormality associate antibody syndrome include paradoxical prolong partial thromboplastin time usually occur disorder positive test antiphospholipid antibody combination find earn term systemic lupus erythematosus
autoantibody find systemic lupus erythematosus anti-cardiolipin antibody cause false positive test syphilis
citation need heart
systemic lupus erythematosus cause outer line surround heart myocarditisinflammation heart muscle endocarditisinflammation inner line heart
endocarditis systemic lupus erythematosus non-infectious call
involve mitral valve tricuspid valve
occur advance rapidly general population
systemic lupus erythematosus cause pain well inflammation pleurae known pleurisy rarely give rise shrink lung syndrome involve reduce lung volume associate lung condition include chronic diffuse interstitial lung disease pulmonary hypertension pulmonary pulmonary hemorrhage
passage blood protein urine present sign kidney involvement
acute chronic renal impairment develop systemic lupus erythematosus lead acute end-stage kidney failure
early recognition management systemic lupus erythematosus end-stage renal failure occur case black population risk time higher
histological hallmark systemic lupus erythematosus membranous wire loop abnormality find due immune complex deposition glomerular basement membrane lead typical granular appearance immunofluorescence test
further information systemic lupus erythematosus
syndrome result systemic lupus erythematosus affect central peripheral nervous system
american college rheumatology define neuropsychiatric syndrome systemic lupus erythematosus diagnosis neuropsychiatric syndrome concurrent systemic lupus erythematosus term np systemic lupus erythematosus difficult challenge medicine involve different pattern symptom mistaken sign infectious disease stroke
common neurological disorder people systemic lupus erythematosus headache existence specific systemic lupus erythematosus headache optimal approach headache systemic lupus erythematosus case remain controversial common neuropsychiatric manifestation systemic lupus erythematosus include cognitive dysfunction mood disorder cerebrovascular disease seizure anxiety disorder psychosis depression extreme case personality disorder psychosis occur result treate disease rarely present intracranial hypertension syndrome characterize elevate intracranial pressure headache occasional abducen nerve absence space-occupy lesion ventricular enlargement normal cerebrospinal fluid chemical hematological constituent
rare manifestation acute state syndrome aseptic meningitis autonomic disorder syndrome manifest multiplex movement disorder specifically chorea myasthenia gravis cranial neuropathy plexopathy
neurological disorder contribute significant percentage morbidity mortality people systemic lupus erythematosus result neural side systemic lupus erythematosus study hope reduce morbidity mortality rate aspect disease severe damage epithelial cell bloodbrain barrier
certain region depression affect women systemic lupus erythematosus eye
eye involvement seen people
common disease dry eye syndrome secondary sjögren syndrome scleritis retinopathy affect eye ischemic optic neuropathy retinal detachment secondary angle-closure glaucoma occur
addition medication use treat systemic lupus erythematosus cause eye disease long-term glucocorticoid use cause cataract secondary open-angle glaucoma long-term hydroxychloroquine treatment cause vortex reproductive further information systemic lupus erythematosus pregnancy
systemic lupus erythematosus cause increase rate fetal death utero spontaneous abortion miscarriage
overal live-birth rate people systemic lupus erythematosus estimate pregnancy outcome appear worse people systemic lupus erythematosus disease flare pregnancy
systemic lupus erythematosus occurrence systemic lupus erythematosus symptom infant born mother systemic lupus erythematosus commonly present rash resemble systemic lupus erythematosus sometime systemic abnormality heart block enlargement liver spleen systemic lupus erythematosus usually benign self-limit systemic
fatigue systemic lupus erythematosus probably multifactorial relate disease activity complication hypothyroidism pain depression poor sleep quality poor physical fitness lack social support cause
systemic lupus erythematosus presumably cause genetic susceptibility couple environmental trigger result defect immune system
factor associate systemic lupus erythematosus vitamin deficiency genetics
systemic lupus erythematosus run family single causal gene identify
instead multiple gene appear influence person chance develop systemic lupus erythematosus trigger environmental factor
hla class class class gene associate systemic lupus erythematosus class contribute independently increase risk systemic lupus erythematosus gene contain risk variant systemic lupus erythematosus irf5 cdkn1a blk susceptibility gene population specific genetic study rate disease family support genetic basis disease heritability identical monozygotic twin found share susceptibility disease rate compare fraternal dizygotic twin full sible show concordance share inheritance
systemic lupus erythematosus associate genetic region likely oligogenic trait mean gene control susceptibility disease
systemic lupus erythematosus regard prototype disease due significant overlap symptom autoimmune disease drug reaction
systemic lupus erythematosus erythematosus generally reversible condition usually occur people treate long-term illness
systemic lupus erythematosus mimics systemic lupus erythematosus
symptom drug-induce systemic lupus erythematosus generally disappear medication trigger episode stop
medication cause condition common procainamide quinidine phenytoin form systemic lupus erythematosus
cutaneous systemic lupus erythematosus limit skin symptom diagnose biopsy rash face neck scalp arm
approximately people progress systemic lupus erythematosus pathophysiology
systemic lupus erythematosus trigger environmental factor unknown
systemic lupus erythematosus body immune system produce antibody particularly protein cell nucleus
antibody attack immediate cause systemic lupus erythematosus
systemic lupus erythematosus chronic inflammatory disease believe type hypersensitivity response potential type involvement acral pigmentation consider possible manifestation systemic lupus erythematosus high titer anti-cardiolipin antibody consequence therapy
people systemic lupus erythematosus intense polyclonal b-cell activation population shift immature b cell
memory cell increase cd27igdare susceptible immunosuppression
memory cell associate increase disease activity renal systemic lupus erythematosus
cell regulate b-cell response infiltrate target tissue defect adhesion gene transcription alternative splice
cytokine bly interleukin interleukin interleukin type interferon tumor necrosis factor
involve inflammatory process potential therapeutic target
complement system low c3 level associate systemic lupus erythematosus cell death
increase monocyte expression fa b cell t cell increase correlation apoptotic rate lymphocyte disease activity
increase t lymphocyte
body macrophage large phagocytic cell germinal center secondary lymph node express protein
cell normally engulf cell undergone apoptosis somatic hypermutation
people systemic lupus erythematosus significantly tbm found cell rarely contain material apoptotic b cell
apoptotic nucley found outside
material present threat tolerization cell t cell
cell germinal center endocytose antigenic material present t cell activate
apoptotic chromatin nucley attach surface dendritic cell make material available activate cell randomly acquire somatic hypermutation pro-inflammatory form cell death increase t lymphocyte due mitochondrial dysfunction oxidative stress depletion atp clearance deficiency clearance deficiency
impair clearance dy cell potential pathway development systemic autoimmune disease
include deficient phagocytic activity scant serum component addition increase apoptosis
systemic lupus erythematosus associate defect apoptotic clearance damage effect cause apoptotic debris
early apoptotic cell express eat-me signal cell-surface protein prompt immune cell engulf
cell express signal attract macrophage dendritic cell
apoptotic material remove correctly phagocyte capture instead cell lead development antinuclear antibody
isolate whole blood people systemic lupus erythematosus show reduce expression surface molecule involve uptake apoptotic cell
monocyte body macrophage found germinal centre lymph node even show definitely different morphology smaller scarce die earlier
serum component complement factor crp glycoprotein furthermore decisively important efficiently operate
systemic lupus erythematosus component miss diminish inefficient
recent research found association certain people systemic lupus erythematosus especially systemic lupus erythematosus nephritis impairment degrade neutrophil extracellular trap
due inhibit factor net protect factor people serum abnormality dnase1 mutation systemic lupus erythematosus far found japanese cohort
clearance early apoptotic cell important function multicellular organism
lead progression apoptosis process finally secondary necrosis cell ability disturb
cell release nuclear fragment potential well internal danger signal induce maturation dendritic cell dcs lost membrane integrity
increase appearance apoptotic cell stimulate inefficient clearance
lead maturation dcs presentation intracellular antigen late apoptotic secondary necrotic cell mhc molecule
possibly result extend exposure nuclear intracellular autoantigen derive late apoptotic secondary necrotic cell
b t cell tolerance apoptotic cell abrogate lymphocyte get activate autoantigen inflammation production autoantibody plasma cell initiate
clearance deficiency skin apoptotic cell observe people cutaneous systemic lupus erythematosus cle center centre person systemic lupus erythematosus control schematic
red body macrophage black positive apoptotic cell healthy donor florid germinal centre show giant tingible body macrophage tbm contain ingest apoptotic cell uningest apoptotic cell tbm people lymphoma show small tingible body macrophage tbm contain ingest apoptotic cell uningest apoptotic cell tbm systemic lupus erythematosus show lack tbm apoptotic cell decorate surface cell presumably follicular dendritic cell systemic lupus erythematosus people systemic lupus erythematosus show tbm contain ingest apoptotic cell apoptotic cell tbm systemic lupus erythematosus
people systemic lupus erythematosus show normal germinal centre
healthy condition apoptotic lymphocyte remove germinal center gc specialize phagocyte tingible body macrophage tbm free apoptotic potential autoantigenic material seen
people systemic lupus erythematosus build apoptotic debris observe gc ineffective clearance apoptotic cell
close proximity tbm dendritic cell fdc localise gc attach antigen material surface contrast bone dc neither take present mhc molecule
autoreactive b cell accidentally emerge somatic hypermutation migrate germinal center light zone
autoreactive b cell coincidentally normally receive survival signal antigen plant dendritic cell perish apoptosis
case clearance deficiency apoptotic nuclear debris accumulate light zone gc get attach fdc
serve germinal centre survival signal b-cell
migration mantle zone b cell require further survival signal helper cell promote maturation plasma cell b memory cell
presence autoreactive t cell chronic autoimmune disease consequence
autoantibody nrnp nrnp c initially target restrict proline-rich motif
antibody bind subsequently spread epitope
similarity cross-reactivity initial target nrnp sm autoantibody identify likely commonality cause focal point intermolecular epitope spread
expression hmgb1 found people mice systemic lupus erythematosus high mobility group box nuclear protein participate chromatin architecture transcriptional regulation
recently increase evidence contribute pathogenesis chronic inflammatory autoimmune disease due inflammatory immune stimulate property diagnosis show interface dermatitis seen systemic lupus erythematosus
micrograph section human skin prepare direct immunofluorescence use anti-igg antibody
skin person systemic lupus erythematosus show igg deposit different place
bandlike deposit epidermal basement membrane systemic lupus erythematosus band test positive second nucley epidermal cell antibody present
laboratory test
antibody test nuclear antigen form mainstay test systemic lupus erythematosus
technique use detect
clinically widely use method indirect immunofluorescence
pattern fluorescence suggest type antibody present people serum
direct immunofluorescence detect deposit immunoglobulin complement protein people skin
skin expose sun test positive direct so-cal systemic lupus erythematosus band test evidence systemic lupus erythematosus
screen yield positive result connective tissue disorder autoimmune disease occur normal individual
subtypes antibody include anti-smith anti-double strand dna antibody link systemic lupus erythematosus anti-histone antibody link drug-induce systemic lupus erythematosus
antibody highly specific systemic lupus erythematosus present case appear people systemic lupus erythematosus anti-dsdna antibody tend reflect disease activity case occur people systemic lupus erythematosus anti-u1 appear systemic sclerosis mix connective tissue disease anti-ro ss-b anti-la common syndrome
confer specific risk heart conduction block neonatal systemic lupus erythematosus
test routinely perform suspect systemic lupus erythematosus complement system level low level suggest consumption immune system electrolyte kidney function disturb kidney involve liver enzyme complete blood count
systemic lupus erythematosus le cell test commonly use diagnosis longer use le cell found 5075 systemic lupus erythematosus case found people rheumatoid arthritis drug sensitivity
le cell test perform rarely mostly historical significance diagnostic criteria
physician make diagnosis basis american college acr classification criteria
criteria establish mainly use scientific research use randomize control trial require higher confidence level people systemic lupus erythematosus pass full criteria
american college rheumatology acr establish criteria revise classificatory instrument operationalise definition systemic lupus erythematosus clinical trial
intend use diagnose individual well capacity
purpose identify people clinical study person systemic lupus erythematosus symptom present simultaneously serially separate occasion
rash rash cheek sensitivity specificity rash red scaly patche skin cause scare sensitivity specificity inflammation membrane lung inflammation membrane heart sensitivity specificity pleural sensitive cardiac specific oral ulcer include oral nasopharyngeal ulcer sensitivity specificity arthritis arthritis peripheral joint tenderness swell effusion sensitivity specificity exposure ultraviolet light cause rash symptom systemic lupus erythematosus flareup sensitivity specificity low red blood cell count white blood cell 1500l low platelet count absence offend drug sensitivity specificity seen consumption c3 immune complex-induce inflammation congenitally complement deficiency predispose systemic lupus erythematosus
renal disorder g day protein urine cellular cast seen urine microscope sensitivity specificity antibody test positive sensitivity specificity disorder positive dna antibody false positive serological test syphilis sensitivity specificity presence dna case positive rheumatic disease healthy person disorder psychosis sensitivity specificity
acr criteria people systemic lupus erythematosus
fever f c extreme fatigue hair loss finger turn white blue cold raynaud phenomenon
criteria individual diagnosis
people especially syndrome systemic lupus erythematosus above criteria systemic lupus erythematosus present feature list criteria
partition use identify parsimonious criteria analysis present diagnostic classification tree
classification tree systemic lupus erythematosus diagnose person immunologic disorder antibody antibody false positive syphilis test le cell rash
sensitivity specificity
full classification tree use criteria
sensitivity specificity
alternative criteria suggest eg st
thomas hospital alternative criteria treatment
treatment systemic lupus erythematosus involve prevent flare reduce severity duration occur
treatment include corticosteroid anti-malarial drug
certain type systemic lupus erythematosus nephritis diffuse proliferative glomerulonephritis require intermittent cytotoxic drug
drug include cyclophosphamide mycophenolate
increase risk develop infection pancrea problem high blood sugar high blood pressure
approve fda systemic lupus erythematosus drug approve disease use systemic lupus erythematosus off-label
november fda advisory panel recommend approve benlysta treatment pain common systemic lupus erythematosus
drug approve fda march
due variety symptom organ system involvement systemic lupus erythematosus severity individual assess order successfully treat systemic lupus erythematosus
mild remittent disease sometime safely left untreate
require anti-inflammatory drug antimalarial use
medication prednisone acid use past
antirheumatic drug
antirheumatic drug use preventively reduce incidence flare progress disease need steroid use flare occur treate corticosteroid
commonly use antimalarial hydroxychloroquine immunosuppressant eg azathioprine
fda-approve antimalarial use constitutional cutaneous articular manifestation
relatively side effect evidence improve survival people systemic lupus erythematosus cyclophosphamide use severe glomerulonephritis organ-damage complication
acid use treatment systemic lupus erythematosus fda-approve indication fda investigate report associate birth defect use pregnant women drug
severe case medication modulate immune system primarily corticosteroid immunosuppressant use control disease prevent recurrence symptom known flare
dosage people require steroid develop syndrome symptom include obesity puffy face diabete mellitus increase appetite difficulty sleep osteoporosis
subside large initial dosage reduce long-term use even low dose cause elevate blood pressure cataract
numerous new immunosuppressive drug actively test systemic lupus erythematosus
suppress immune system corticosteroid target response individual type immune cell
drug fda-approve treatment rheumatoid arthritis due high-toxicity use limit
large percentage people systemic lupus erythematosus vary amount chronic pain stronger prescription analgesics painkiller use over-the-counter drug mainly nonsteroidal anti-inflammatory drug provide effective relief
potent nsaids indomethacin relatively contraindicate people systemic lupus erythematosus increase risk kidney failure heart failure
pain typically treate opioid vary potency base severity symptom
opioid use prolong period drug tolerance chemical dependency addiction occur
addiction typically concern condition likely ever completely disappear
lifelong treatment opioid fairly common chronic pain symptom accompany periodic titration typical long-term opioid regimen
intravenous immunoglobulin
intravenous immunoglobulin use control systemic lupus erythematosus organ involvement vasculitis
believe reduce antibody production promote clearance immune complexe body even mechanism action well understood immunosuppressive corticosteroid suppress immune system risk serious infection drug lifestyle change
avoid sunlight systemic lupus erythematosus critical sunlight known exacerbate skin manifestation disease
avoid activity induce fatigue important systemic lupus erythematosus fatigue easily debilitate
problem lead people becom housebound long period time
drug unrelate systemic lupus erythematosus prescribe known exacerbate disease
occupational exposure silica pesticide mercury worsen disease kidney transplantation
kidney transplant treatment choice kidney disease complication systemic lupus erythematosus recurrence full disease common people syndrome
approximately people systemic lupus erythematosus clinically significant level antiphospholipid antibody associate syndrome syndrome relate onset neural systemic lupus erythematosus symptom brain
form disease cause different systemic lupus erythematosus thrombose blood clot sticky blood form blood vessel prove fatal move blood stream thrombose migrate brain potentially cause stroke block blood supply brain
disorder suspect people brain scan usually require early detection
scan show localize area brain blood supply adequate
treatment plan people require
aspirin prescribe purpose case involve thrombosis use management pregnancy further information systemic lupus erythematosus pregnancy
infant born mother systemic lupus erythematosus healthy pregnant mother systemic lupus erythematosus remain medical care delivery
systemic lupus erythematosus rare identification mother highest risk complication allow prompt treatment birth
addition systemic lupus erythematosus flare pregnancy proper treatment maintain health mother longer
women pregnant known anti-ro ssa anti-la antibody ssb echocardiogram week pregnancy monitor health heart surround vasculature
reliable form pregnancy prevention routinely advise women systemic lupus erythematosus get pregnant active disease found harmful
systemic lupus erythematosus nephritis common manifestation
cure available systemic lupus erythematosus treatment disease
people diagnose systemic lupus erythematosus live year
today survive year live relatively expect live normal lifespan mortality rate elevate compare people systemic lupus erythematosus
typically worse men children women symptom present age disease tend run benign course
early mortality year due organ failure overwhelm infection alter early diagnosis treatment
mortality risk fivefold compare normal population late stage attribute cardiovascular disease accelerate atherosclerosis lead cause death people systemic lupus erythematosus reduce potential cardiovascular issue high blood pressure high cholesterol prevent treate aggressively
use lowest dose shortest possible period drug reduce symptom use whenever possible epidemiology
global rate systemic lupus erythematosus approximately 2070 people
female rate highest year age
lowest overal rate exist iceland japan
highest rate exist france
sufficient evidence conclude systemic lupus erythematosus common country compare environmental variability country
example different country receive different level sunlight exposure uv ray affect dermatological symptom systemic lupus erythematosus
certain study hypothesize genetic connection exist race systemic lupus erythematosus affect disease prevalence
true racial composition country affect disease cause incidence country change racial makeup change
order understand true country largely homogenous racially stable population study better understand incidence rate disease develop world unclear
rate systemic lupus erythematosus vary country ethnicity sex change time united states estimate rate systemic lupus erythematosus estimate place total affect population 322000 northern europe rate people systemic lupus erythematosus occur frequently greater severity non-european descent rate found high afro-caribbean descent systemic lupus erythematosus generally present age time common girl
onset persistence systemic lupus erythematosus show disparity gender socioeconomic status play major role
women systemic lupus erythematosus lower socioeconomic status show higher depression score higher body mass index restrict access medical care women higher socioeconomic statuse illness
people systemic lupus erythematosus self-report anxiety depression score lower socioeconomic status
assertion race affect rate systemic lupus erythematosus
review study correlate race systemic lupus erythematosus identify source systematic methodological error indicate connection race systemic lupus erythematosus spurious example study show social support modulate factor buffer systemic lupus erythematosus -relate damage maintain physiological functionality study conduct determine people different racial background receive differ level social support difference act confound variable study correlate race systemic lupus erythematosus
caveat note examine study systemic lupus erythematosus symptom self-report
process introduce additional source methodological error
study show self-report data affect patient experience disease- social support level helplessness abnormal illness-relate factor self-assessment
additionally factor degree social support person receive socioeconomic status health insurance access care contribute individual disease progression racial difference systemic lupus erythematosus progression found study control socioeconomic status se participant study control se participant found non-white people abrupt disease onset compare white people disease progress quickly
patient report hematological serosal neurological renal symptom
severity symptom mortality similar white non-white patient
study report different rate disease progression late-stage systemic lupus erythematosus likely reflect difference socioeconomic status correspond access care people receive medical care accru damage likely poverty line additional study found education marital status occupation income create social context contribute disease progression sex
systemic lupus erythematosus autoimmune disease affect female frequently male rate chromosome carry immunological relate gene mutate contribute onset systemic lupus erythematosus
y chromosome identify mutation associate autoimmune disease
mechanism explain increase incidence systemic lupus erythematosus female
onset systemic lupus erythematosus attribute elevate hydroxylation estrogen abnormally decrease level androgen female
addition difference signal show contribute onset systemic lupus erythematosus
female likely relapse male intensity relapse sexe
addition hormonal mechanism specific genetic influence found chromosome contribute development systemic lupus erythematosus
study indicate chromosome determine level sex hormone
study show association syndrome systemic lupus erythematosus
male systemic lupus erythematosus abnormal translocation result partial triplication par1 gene region chang rate disease
rate systemic lupus erythematosus united states increase
increase due better diagnosis increase frequency disease unknown history historical draw systemic lupus erythematosus erythematosus
history systemic lupus erythematosus divide period classical neoclassical modern
period research documentation advance understand diagnosis systemic lupus erythematosus lead classification autoimmune disease various diagnostic option treatment available people systemic lupus erythematosus
advance made medical science diagnosis treatment systemic lupus erythematosus dramatically improve life expectancy person diagnose systemic lupus erythematosus etymology
explanation venture term systemic lupus erythematosus
systemic lupus erythematosus latin wolf derive greek red
explanation originate reddish butterfly-shap rash disease classically exhibit nose cheek
various account doctor thought rash resemble pattern fur wolf face
likely derive similarity distribution systemic lupus erythematosus vulgaris chronic facial tuberculosis lesion rage punch said resemble bite wolf
account claim term systemic lupus erythematosus come latin directly term french style mask women reportedly wore conceal rash face
mask call loup french wolf
citation need
classical period
classical period began disease recognize middle age
term systemic lupus erythematosus attribute 12th-century italian physician rogerius use describe sore leg people formal treatment disease exist resource available physician help people limit period
neoclassical period began skin disease known systemic lupus erythematosus document french physician pierre cazenave
term illness systemic lupus erythematosus ad word distinguish disease illness affect skin infectious observe disease people made detail note assist diagnosis
document systemic lupus erythematosus affect adult adolescence early facial rash distinguish feature
research documentation disease continue neoclassical period work ferdinand von son-in-law moritz kaposi
document physical effect systemic lupus erythematosus well insight possibility disease cause internal trauma
von hebra observe systemic lupus erythematosus symptom last year disease go dormant year aggressive activity re-appear symptom general pattern
observation led hebra term systemic lupus erythematosus chronic disease
kaposi observe systemic lupus erythematosus assume form skin lesion known systemic lupus erythematosus aggravate form affect skin cause fever arthritis systemic disorder people present rash confine face appear cheek bridge nose call butterfly rash
kaposi observe patient develop butterfly rash rash afflict disease tuberculosis cause death kaposi people recognize term systemic lupus erythematosus documentation remit relapse nature disease relationship skin systemic manifestation disease activity
century research systemic lupus erythematosus continue work sir william publish paper internal complication exudativum multiforme
patient case paper systemic lupus erythematosus work expand knowledge systemic disease document extensive critical visceral complication disease systemic lupus erythematosus note people systemic lupus erythematosus disease affect skin organ body well osler ad word systemic term systemic lupus erythematosus erythematosus distinguish type disease systemic lupus erythematosus paper note special feature disease attack sustain month even year
further study disease led paper publish document affliction arthritis pneumonia inability form coherent idea delirium central nervous system damage affect patient diagnose systemic lupus erythematosus modern period
modern period begine saw major development research cause treatment discoid systemic systemic lupus erythematosus
research conduct led detail pathologic description systemic lupus erythematosus demonstrate disease affect kidney heart lung tissue major breakthrough made discovery le cell systemic lupus erythematosus cella misnomer occur disease well
discover team researcher mayo clinic discover white blood cell contain nucleus cell push white cell proper nucleus note invade nucleus coat antibody allow ingest phagocytic scavenger cell name antibody cause cell ingest le factor nucley cell result le cell le cell determine part anti-nuclear antibody reaction body produce antibody tissue
discovery led definitive test systemic lupus erythematosus le cell found approximately people diagnose systemic lupus erythematosus le cell test rarely perform definitive systemic lupus erythematosus test today le cell alway occur people systemic lupus erythematosus occur individual autoimmune disease
presence helpful establish diagnosis longer indicate definitive systemic lupus erythematosus diagnosis
discovery le cell led further research result definitive test systemic lupus erythematosus
build knowledge systemic lupus erythematosus auto-antibody attach nucley normal cell cause immune system send white blood cell fight invader test develop look anti-nuclear antibody le cell specifically
ana test easier perform led definitive diagnosis systemic lupus erythematosus relate disease
discovery led understand known autoimmune disease
ensure person systemic lupus erythematosus autoimmune disease american college rheumatology acr establish list clinical immunologic criteria combination point systemic lupus erythematosus
criteria include symptom person identify eg pain thing physician detect physical examination laboratory test result
list originally compil initially revise further revise improve
medical historian theorize people porphyria disease share symptom systemic lupus erythematosus generate folklore story vampire werewolve photosensitivity scare hair growth porphyrin stain teeth severe recessive form porphyria combination disorder known dual homozygous compound heterozygous porphyria
useful medication disease found quinine report effective therapy
year later use salicylate conjunction quinine note greater benefit
best available treatment middle century discover efficacy corticosteroid treatment systemic lupus erythematosus research
study call test drug fully human monoclonal anti-baff antibody baff stimulate extend life lymphocyte produce antibody foreign self cell approve fda march engineer immune cell study animal model disease 2019 see
canine discoid systemic lupus erythematosus erythematosus dog
